UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 162

Sortiert nach

Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study

Leukemia, 2020-08, Vol.34 (8), p.2125-2137

2020

Volltextzugriff (PDF)

Effects of MSC Coadministration and Route of Delivery on Cord Blood Hematopoietic Stem Cell Engraftment

Cell transplantation, 2013-01, Vol.22 (7), p.1171-1183

2013

Volltextzugriff (PDF)

Effect of vitamin D treatment in chronic GVHD

Bone marrow transplantation (Basingstoke), 2011-10, Vol.46 (10), p.1395-1397

2011

Volltextzugriff (PDF)

P1361: TREATMENT OF SEVERE STEROID‐REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE‐BLIND MULTI‐CENTER HOVON‐113 TRIAL

HemaSphere, 2022-06, Vol.6 (Suppl), p.1245-1246

2022

Volltextzugriff (PDF)

Ischemic stroke associated with the infusion of DMSO-cryopreserved auto-PBSCs

Bone marrow transplantation (Basingstoke), 2011-07, Vol.46 (7), p.1035-1036

2011

Volltextzugriff (PDF)

The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes

Haematologica (Roma), 2008-09, Vol.93 (9), p.1301-1309

2008

Volltextzugriff (PDF)

Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients

Haematologica (Roma), 2012-08, Vol.97 (8), p.1218-1224

2012

Volltextzugriff (PDF)

Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation

Bone marrow transplantation (Basingstoke), 2019-05, Vol.54 (5), p.757-761

2019

Volltextzugriff (PDF)

Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia

Annals of hematology, 2022-10, Vol.101 (10), p.2263-2270

2022

Volltextzugriff (PDF)

Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients

Haematologica (Roma), 2013-03, Vol.98 (3), p.437-443

2013

Volltextzugriff (PDF)

Influence of donor age in allogeneic stem cell transplant outcome in acute myeloid leukemia and myelodisplastic syndrome

Leukemia research, 2015-08, Vol.39 (8), p.828-834

2015

Volltextzugriff (PDF)

P837: ELTROMBOPAG (EPAG) INDUCES HEMATOLOGIC RESPONSES FOR PATIENTS WITH POST‐ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANT POOR GRAFT FUNCTION (POST‐ALLO HSCT PGF): RESULTS OF THE ELTION STUDY IN SPAIN

HemaSphere, 2022-06, Vol.6 (Suppl), p.731-732

2022

Volltextzugriff (PDF)

Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation

Biology of blood and marrow transplantation, 2018-11, Vol.24 (11), p.2365-2370

2018

Volltextzugriff (PDF)

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

The New England journal of medicine, 2013-11, Vol.369 (19), p.1783-1796

2013

Volltextzugriff (PDF)

Results of a prospective phase II trial with ofatumumab as part of reduced intensity conditioning regimen in high‐risk non‐Hodgkin B lymphoma patients: A GELTAMO trial

Hematological oncology, 2017-06, Vol.35 (S2), p.346-347

2017

Volltextzugriff (PDF)

29 MICROVESICLES/EXOSOMES DERIVED FROM BONE MARROW MESENCHYMAL STROMAL CELLS (MSC) ARE INVOLVED IN THE INTERCELLULAR COMMUNICATION BETWEEN HEMATOPOIETIC CELLS AND BM MICROENVIRONMENT IN MDS PATIENTS

Leukemia research, 2015-04, Vol.39, p.S12-S13

2015

Volltextzugriff (PDF)

Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies

Transplantation, 2013-05, Vol.95 (10), p.1284

2013

Volltextzugriff (PDF)

The marrow cell continuum: stochastic determinism

Folia histochemica et cytobiologica, 2005-01, Vol.43 (4), p.187-190

2005

Volltextzugriff (PDF)

C013 Genomic aberrations observed in mesenchymal stem cells from 5q-syndrome could be involved in the pathophysiology of the disease

Leukemia research, 2009-05, Vol.33, p.S38-S39

2009

Volltextzugriff (PDF)

Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population

Haematologica (Roma), 2009-07, Vol.94 (7), p.975-983

2009

Volltextzugriff (PDF)

Immunophenotypic analysis of Waldenstrom's macroglobulinemia

Seminars in oncology, 2003-04, Vol.30 (2), p.187-195

2003

Volltextzugriff (PDF)

Optimisation of mesenchymal stromal cells karyotyping analysis: implications for clinical use

Transfusion medicine (Oxford, England), 2012-04, Vol.22 (2), p.122-127

2012

Volltextzugriff (PDF)

Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial

Haematologica (Roma), 2011-07, Vol.96 (7), p.1072-1076

2011

Volltextzugriff (PDF)

1 – 25 von 162

Suche als RSS-Feed

Aktive Filter

ThemaBone Marrow

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(145)
Mit Volltextzugriff
(123)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study

Effects of MSC Coadministration and Route of Delivery on Cord Blood Hematopoietic Stem Cell Engraftment

Effect of vitamin D treatment in chronic GVHD

P1361: TREATMENT OF SEVERE STEROID‐REFRACTORY ACUTE GVHD WITH MESENCHYMAL STROMAL CELLS: RESULTS OF THE PHASE III RANDOMIZED DOUBLE‐BLIND MULTI‐CENTER HOVON‐113 TRIAL

Ischemic stroke associated with the infusion of DMSO-cryopreserved auto-PBSCs

The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes

Impaired expression of DICER, DROSHA, SBDS and some microRNAs in mesenchymal stromal cells from myelodysplastic syndrome patients

Usefulness of eltrombopag for treating thrombocytopenia after allogeneic stem cell transplantation

Real-life analysis on safety and efficacy of asciminib for ponatinib pretreated patients with chronic myeloid leukemia

Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients

Influence of donor age in allogeneic stem cell transplant outcome in acute myeloid leukemia and myelodisplastic syndrome

P837: ELTROMBOPAG (EPAG) INDUCES HEMATOLOGIC RESPONSES FOR PATIENTS WITH POST‐ALLOGENIC HEMATOPOIETIC STEM CELL TRANSPLANT POOR GRAFT FUNCTION (POST‐ALLO HSCT PGF): RESULTS OF THE ELTION STUDY IN SPAIN

Immune effector cell-associated hematotoxicity: EHA/EBMT consensus grading and best practice recommendations

Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation

A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias

Results of a prospective phase II trial with ofatumumab as part of reduced intensity conditioning regimen in high‐risk non‐Hodgkin B lymphoma patients: A GELTAMO trial

29 MICROVESICLES/EXOSOMES DERIVED FROM BONE MARROW MESENCHYMAL STROMAL CELLS (MSC) ARE INVOLVED IN THE INTERCELLULAR COMMUNICATION BETWEEN HEMATOPOIETIC CELLS AND BM MICROENVIRONMENT IN MDS PATIENTS

Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies

P756: ALLOGENEIC STEM CELL TRANSPLANTATION IN MYELODYSPLASTIC SYNDROME/MYELOPROLIFERATIVE NEOPLASM (MDS/MPN) OVERLAP SYNDROMES. A SINGLE CENTER EXPERIENCE AND DISSECTION OF MUTATIONAL PROFILE

The marrow cell continuum: stochastic determinism

C013 Genomic aberrations observed in mesenchymal stem cells from 5q-syndrome could be involved in the pathophysiology of the disease

Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population

Immunophenotypic analysis of Waldenstrom's macroglobulinemia

Optimisation of mesenchymal stromal cells karyotyping analysis: implications for clinical use

Mesenchymal stem cells expanded in vitro with human serum for the treatment of acute and chronic graft-versus-host disease: results of a phase I/II clinical trial

Aktive Filter

Suchergebnisse filtern